z-logo
open-access-imgOpen Access
Increased human immunodeficiency virus type 1 Env expression and antibody induction using an enhanced alphavirus vector
Author(s) -
Mattias N. E. Forsell,
Gerald M. McInerney,
Pia Dosenovic,
Åsa Hidmark,
Christopher Eriksson,
Peter Liljeström,
Christoph Grundner,
Gunilla B. Karlsson Hedestam
Publication year - 2007
Publication title -
journal of general virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.55
H-Index - 167
eISSN - 1465-2099
pISSN - 0022-1317
DOI - 10.1099/vir.0.83060-0
Subject(s) - biology , virology , heterologous , semliki forest virus , antigen , antibody , alphavirus , vector (molecular biology) , immune system , virus , viral vector , recombinant dna , immunology , rna , gene , genetics
Viral vectors encoding heterologous vaccine antigens are potent inducers of cellular immune responses, but they are generally less efficient at stimulating humoral immunity. To improve the induction of antibody responses by Semliki Forest virus-based vaccines, a vector encoding a translation-enhancer element and a novel internal signal sequence for increased expression and secretion of soluble antigens was designed. Approximately tenfold more human immunodeficiency virus type 1 gp120 was secreted into culture supernatants of infected cells using the enhanced vector compared with the parental vector. This translated into a significant increase in gp120-specific antibodies in immunized mice, suggesting that antigen-expression levels from the parental vector are limiting for induction of antibody responses. These data encourage the use of the enhanced vector for elicitation of immune responses against heterologous antigens during vaccination.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom